Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

385

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

September 28, 2025

Study Completion Date

September 28, 2025

Conditions
RSV InfectionhMPV
Interventions
BIOLOGICAL

RSV/hMPV vaccine dose A1

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose A2

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose A3

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose B1

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose B2

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose B3

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose C1

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose C2

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose C3

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose 1

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose 2

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

RSV/hMPV vaccine dose 3

Suspension for injection. Route of administration: IM injection

BIOLOGICAL

Monovalent RSV Vaccine

Suspension for injection. Route of administration: IM injection

Trial Locations (6)

2019

Site # 0361004, Botany

2100

Site # 031001, Brookvale

2228

Site # 0361006, Miranda

2500

Site # 0361002, Wollongong

4006

Site # 0361003, Herston

4101

Site # 0361005, South Brisbane

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY